Regulation

NPA CEO on CBD: ‘Folks need to take the front door with FDA’

NOTES FROM SUPPLYSIDE WEST 2018

NPA CEO on CBD: ‘Folks need to take the front door with FDA’

By Stephen Daniells

The Natural Products Association’s stance on CBD is to take FDA’s word on the controversial ingredient, until someone takes the front door with the Agency and files an NDI or a GRAS notification with the FDA for CBD.

© Getty Images / Dmitry_Tishchenko

Top FDA official: ‘Anyone who thinks CBD is lawful is mistaken’

By Stephen Daniells

“Just because we haven’t taken enforcement action people seem to think it [CBD] is OK,” said Steven Tave, director of the FDA’s Office of Dietary Supplement Programs, at a recent industry conference. “Anyone who thinks it is lawful is mistaken.”

Marketing CBD is mostly about risk tolerance, legal expert says

Marketing CBD is mostly about risk tolerance, legal expert says

By Hank Schultz

The source of CBD should be of concern for the companies marketing the ingredient, said a legal expert at a recent dietary supplement industry event. But he also said the regulatory landscape for the ingredient is shifting so fast that any opinions he...

Follow us

Products

View more

Webinars